Contract development and manufacturing organizations are among the most operationally complex businesses in life sciences. A mid-sized CDMO may be running drug substance development, clinical manufacturing, commercial scale-up, and technology transfer projects simultaneously for a dozen different client sponsors — each with its own timeline, quality requirements, and reporting expectations.
The administrative demands of that complexity are substantial. Batch record compilation, deviation tracking, client status reports, milestone log updates, change control documentation, and project schedule maintenance all have to happen continuously and accurately for the CDMO to maintain both GMP compliance and client confidence. The global CDMO market is projected to reach $226 billion by 2030 according to Grand View Research, and competition for long-term client relationships means that operational reliability is as important as scientific capability.
Batch Record Documentation: The GMP Backbone
A batch manufacturing record (BMR) is the complete, step-by-step account of every action taken during the production of a drug batch. Under 21 CFR Part 211 and ICH Q7, CDMOs must maintain executed batch records for each production run, with every step completed and initialed, every in-process check recorded, every deviation noted and cross-referenced to an investigation record.
Compiling a batch record after production involves reviewing the executed document for completeness, confirming that all required fields are populated and signatures are in place, cross-referencing against the approved master batch record, attaching all relevant analytical data and certificates of analysis, and indexing the complete package in the document management system (common platforms include Veeva Vault QualityDocs, MasterControl, or Documentum).
A CDMO virtual assistant handles the organizational and completeness-checking layer of batch record processing. The VA works from a defined completeness checklist provided by the quality team, flags any missing entries or signature gaps to the responsible production associate, tracks resolution of those gaps, and assembles the finalized document package for QA review. This does not replace the QA review itself — it ensures that the QA reviewer receives a complete package rather than an incomplete draft that generates review cycles.
According to a 2023 survey by the Parenteral Drug Association (PDA), incomplete batch records are among the top five reasons for manufacturing deviations and lot release delays. A systematic VA-supported completeness check before QA review reduces that failure mode.
Client Project Milestone Tracking
Client-facing project management at a CDMO requires consistent, transparent communication about where every program stands. Sponsors — particularly early-stage biotechs that have bet significant capital on a manufacturing partnership — want to know when analytical method development is complete, when GMP manufacturing is scheduled to begin, when batch records will be released, and when drug product will ship to a clinical site.
A CDMO project management VA maintains the master milestone tracker for each active client program — typically in a shared Smartsheet, Microsoft Project, or Asana workspace — and generates weekly status reports that the project manager can review and send to the client. The VA logs completed milestones as they are confirmed by the relevant department head, updates projected dates when delays are reported, and flags any milestone that is at risk of slipping beyond the contractual timeline for immediate project manager attention.
For CDMOs managing 20 or more active programs, that milestone maintenance work is a significant time commitment. When it falls to project managers who are simultaneously running technical meetings, managing deviations, and fielding client calls, milestone records degrade — and sponsor trust follows.
Supporting Change Control and Communication Workflows
A VA supporting CDMO operations can also assist with change control documentation — initiating change control request forms when process or material changes are proposed, tracking approval routing status, and logging final disposition once the change is approved or rejected. This administrative layer keeps the change control queue moving without adding to the project manager's workload.
Similarly, the VA can manage client communication calendars — scheduling quarterly business reviews, sending agenda templates in advance, distributing meeting minutes after calls, and archiving all sponsor correspondence in the client project folder.
If your CDMO needs disciplined administrative support for batch record completeness and client milestone reporting, Stealth Agents provides virtual assistants experienced in life sciences manufacturing operations.
Sources
- Grand View Research. "Contract Development and Manufacturing Organization (CDMO) Market Size Report." GrandViewResearch.com, 2024.
- Parenteral Drug Association. "PDA Annual Manufacturing Survey: Top Root Causes of Lot Release Delays." PDA.org, 2023.
- U.S. Food and Drug Administration. "21 CFR Part 211: Current Good Manufacturing Practice for Finished Pharmaceuticals." FDA.gov, updated 2023.